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follow-up, a reduction in major adverse cardiac events (MACE) was observed with
second-generation compared to first-generation DES (5.6 vs. 16.1%, p0.20), driven by
a four-fold decrease in target vessel revascularization (2.9 vs. 14.8%, p0.09), although
not reaching statistical significance. Only 1 patient (1.6%) in the first-generation DES and
none in the second-generation DES had definite stent thrombosis (Table).
Conclusion: In this study of full metal jacket stenting for diffuse lesions, second-
generation DES compared to first-generation DES demonstrated a favorable trend
toward reduction in repeat revascularization and MACE at 1-year with acceptable safety
profile.
Clinical outcomes at 1-year between first and second generation DES
Second-
generation
DES (n36)
First-
generation
DES (n62) P value
Major adverse cardiac events 2 (5.6%) 10 (16.1%) 0.20
Death 1 (2.8%) 1 (1.6%) 1.00
Q-wave myocardial infarction 0 0 -
Target vessel revascularization 1 (2.9%) 9 (14.8%) 0.09
Target lesion revascularization 1 (2.9%) 7 (11.5%) 0.25
Deﬁnite stent thrombosis 0 1 (1.6%) 1.00
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Background: Coronary Artery Disease continues to be a widespread and growing
problem worldwide. Performing PCI on calcified lesions can lead to higher MACE rates
and stent under expansion/malapposition. The Orbit I trial was conducted to evaluate the
safety and performance of the Diamondback 360 Orbital Atherectomy System (OAS)
(Cardiovascular Systems, Inc., St. Paul, MN, USA) for the treatment of calcified coronary
lesions.
Methods: From May 2008 to July 2008, 33 patients were enrolled in ORBIT I study
based on several criteria, including a de novo, coronary lesion with stenosis 50% and
100% and at least one quadrant of calcification via IVUS. The patients were treated with
OAS prior to stent placement. The patients were followed for 36 months at Care Institute
of Medical Sciences, Ahmedabad, India to evaluate the MACE rate.
Results: Of the 33 patients, 90.90% (n30/33) were males with an average age of 54.9
years. The ACC/AHA lesion class was: Type A 6.06% (n2/33); Type B1 33.33%
(n11/33); Type B2 60.60% (n20/33). The % diameter stenosis was 85.75%; lesion
length was 15.90 mm. The procedural success was 97% (32/33) with one case where
IVUS/device was not able to cross the lesion due to severe calcification. All stents were
successfully deployed with 0.3% 1.8% residual stenosis. The observed MACE rate was
as follows: in-hospital 6.06% (n2/33); 30 days 9.09% (n3/33); 6 months 12.12%
(n4/33); 24 months 15.15% (n5/33); and 36 months 18.18% (n6/33). MACE rate
comprised of 2 patients with a non Q-wave MI in-hospital; one patient with non Q-wave
MI at 30 days that led to TLR; and one patient with cardiac death at 6 months, 24
months and 36 months, respectively.
Conclusion: This case series demonstrates that OAS safely and effectively modified
calcified lesions and facilitated stent delivery in this difficult-to-treat plaque morphology,
which continues up to three years post index procedure.
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Background: Out of hospital cardiac arrest (OHCA) has a poor outcome. Recent
non-randomized studies of ECLS (extracorporeal life support) in OHCA suggested
further studies to define population that would benefit from ECLS. Ongoing prospective
randomized study compares prehospital intraarrest hypothermia combined with mechan-
ical chest compressions, intrahospital ECLS and early invasive assessment in refractory
OHCA of presumed cardiac origin compared to a standard of care. This abstract describes
methodology of the trial and results of presimulation and simulation phase.
Methods: Patients with witnessed OHCA without ROSC (return of spontaneous
circulation) after a minimum of 5 minutes of ACLS (advanced cardiac life support) by
emergency medical service (EMS) team are randomized to standard vs. hyperinvasive arm.
In hyperinvasive arm, mechanical compression device together with intranasal evaporative
cooling is instituted and patients are transferred directly to cardiac center under ongoing
cardiopulmonary resuscitation. After admission, ECLS inclusion/exclusion criteria are
evaluated and if achieved, veno-arterial ECLS is started. Invasive investigation and
standard postresuscitation care follows immediately. Patients in standard arm are managed
on scene. When ROSC is achieved, patients are transferred to cardiac center and further
treated as per recent guidelines. During the presimulation phase mechanical chest
compression device has been used routinely in all patients with OHCA, during the
simulation phase patients were to practice the logistics of the study.
Results: Since January until October 2012 we enrolled 40 patients, 32 to presimulation
and 8 to simulation protocol. Average age was 61 years (21-87), 85% were men. Acute
coronary syndrome was the cause in 21 (53%) patients, STEMI 17 (43%), cardiac origin
of OHCA was identified in 63% of patients. Average time until ROSC was 40 minutes,
median 32 minutes (15-120). Twenty (50%) patients survived, CPC (Cerebral
Performance Category) 12 during hospitalization reached 15 of 20 survivors
(75%) and 1 of 20 nonsurvivors (5%). Survival in patients admitted under ongoing
CPR was 5 of 17 (30%).
Discussion: A combined, hyperinvasive approach to refractory OHCA is a viable option
with challenging preliminary results. The protocol is opened for sharing by other cardiac
centers with available ECLS and cathlab teams trained to admit patients with refractory
cardiac arrest under ongoing CPR. Supported by IGA NT 13225-4/2012, registered
under ClinicalTrials.gov NCT01511666.
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Renal Artery Denervation in Chronic Kidney Disease Patients
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Renal Denervation Therapy (RDN) have been proven to be useful in resistant hyperten-
sion patients. The Symplicity Trials did not include patients with renal disease whereas,
a significant number of end stage renal disease (ESRD) patients who have resistant
hypertension despite being on multiple drugs and the benefits of RDN in such patients
have not been reported.
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